Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease -associated pruritus in adult. | June 11, 2023
Cara Therapeutics (CARA) Announces Kapruvia recommended by England s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
A small molecule drug has been recommended by England’s National Institute for Health Care and Excellence (NICE) for the treatment of adults with moderate to severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysis.
Cara Therapeutics Reports First Quarter 2023 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) CEO Christopher Posner sold 3,869 shares of the company’s stock in a transaction on Friday, May 5th. The shares were sold at an average price of $4.40, for a total value of $17,023.60. Following the transaction, the chief executive officer now directly owns 172,514 shares in the company, […]